PUGLISI, Fabio
PUGLISI, Fabio
DMED - DIPARTIMENTO DI MEDICINA
1781P Feasibility of an automated data solution for Binary Alignment Map (BAM) files generated through next generation sequencing (NGS) of circulating tumor DNA (ctDNA)
2021-01-01 Pellizzari, L.; Rossi, N.; Verardo, M.; Spizzo, R.; Belletti, B.; Piazza, C.; Puglisi, F.; Gerratana, L.
[Early breast cancer in pre-menopausal women and endocrine treatment: which factors impact on decision-making process?]
2015-01-01 Bonotto, Marta; Puglisi, Fabio
A Delphi consensus and open debate on the role of first-line bevacizumab for HER2-negative metastatic breast cancer
2016-01-01 Puglisi, Fabio; Bisagni, Giancarlo; Ciccarese, Mariangela; Fontanella, Caterina; Gamucci, Teresa; Leo, Luigi; Molino, Annamaria; Silva, Rosa Rita; Marchetti, Paolo
A fast and validated LC-MS/MS method to quantify lenvatinib in dried blood spot
2023-01-01 Zanchetta, M.; Posocco, B.; Gagno, S.; Poetto, A. S.; Orleni, M.; Canil, G.; Guardascione, M.; Puglisi, F.; Toffoli, G.
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: The virtual experience of the MITO cooperative group
2022-01-01 Bartoletti, M.; Bergamini, A.; Giannone, G.; Nero, C.; Musacchio, L.; Farolfi, A.; Passarelli, A.; Kuhn, E.; Castaldo, D.; Lombardo, V.; Di Palma, T.; Lorusso, D.; Puglisi, F.; De Giorgi, U.; Valabrega, G.; Schettino, C.; Scambia, G.; Capoluongo, E.; Pignata, S.
A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer
2010-01-01 Venturini, M; Bighin, C; Puglisi, Fabio; Olmeo, N; Aitini, E; Colucci, G; Garrone, O; Paccagnella, A; Marini, G; Crinò, L; Mansutti, M; Baconnet, B; Barbato, A; Del Mastro, L.
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer
2021-01-01 Poetto, A. S.; Posocco, B.; Gagno, S.; Orleni, M.; Zanchetta, M.; Iacuzzi, V.; Canil, G.; Buzzo, M.; Montico, M.; Guardascione, M.; Basile, D.; Pelizzari, G.; Alberti, M.; Gerratana, L.; Puglisi, F.; Toffoli, G.
A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study
2018-01-01 Gagno, Sara; D'Andrea, Mario Rosario; Mansutti, Mauro; Zanusso, Chiara; Puglisi, Fabio; Dreussi, Eva; Montico, Marcella; Biason, Paola; Cecchin, Erika; Iacono, Donatella; Russo, Stefania; Cinausero, Marika; Saracchini, Silvana; Gasparini, Giampietro; Sartori, Donata; Bari, Mario; Collovà, Elena; Meo, Rosa; Merkabaoui, Ghassan; Spagnoletti, Ilaria; Pellegrino, Arianna; Gianni, Lorenzo; Sandri, Paolo; Cretella, Elisabetta; Vattemi, Emanuela; Rocca, Andrea; Serra, Patrizia; Fabbri, Maria Agnese; Benedetti, Giovanni; Foghini, Laura; Medici, Michele; Basso, Umberto; Amoroso, Vito; Riccardi, Ferdinando; Baldelli, Anna Maria; Clerico, Mario; Bonura, Salvatore; Saggia, Chiara; Innocenti, Federico; Toffoli, Giuseppe
A novel kindred with familial gastrointestinal stromal tumors caused by a rare kit germline mutation (N655k): Clinico-pathological presentation and tki sensitivity
2020-01-01 Fornasarig, M.; Gasparotto, D.; Foltran, L.; Campigotto, M.; Lombardi, S.; Del Savio, E.; Buonadonna, A.; Puglisi, F.; Sulfaro, S.; Canzonieri, V.; Cannizzaro, R.; Maestro, R.
A Randomized Clinical Trial Investigating an Integrated Nursing Educational Program to Mitigate Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: The NIV-EC Trial
2023-01-01 Mazzega-Fabbro, C.; Polesel, J.; Brusutti, L.; Malnis, E.; Sirelli, C.; Drigo, A.; Manicone, M.; Rizzetto, M.; Lisanti, C.; Puglisi, F.
A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring
2021-01-01 Zanchetta, M.; Iacuzzi, V.; Posocco, B.; Bortolin, G.; Poetto, A. S.; Orleni, M.; Canil, G.; Guardascione, M.; Foltran, L.; Fanotto, V.; Puglisi, F.; Gagno, S.; Toffoli, G.
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients
2018-01-01 Pelizzari, G.; Gerratana, L.; Basile, D.; Zago, S.; Vitale, M. G.; Bartoletti, M.; Lisanti, C.; Fanotto, V.; Corvaja, C.; Bortot, L.; Liguori, A.; Cinausero, M.; Russo, S.; Andreetta, C.; Bonotto, M.; Mansutti, M.; Minisini, A. M.; Curcio, F.; Fasola, G.; Puglisi, F.
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer
2019-01-01 Gagno, S.; Poletto, E.; Bartoletti, M.; Quartuccio, L.; Romualdi, C.; Garziera, M.; Scalone, S.; Sorio, R.; Dreussi, E.; Zanusso, C.; De Mattia, E.; Roncato, R.; Cecchin, E.; Giorda, G.; De Vita, S.; Dal Bo, M.; Puglisi, F.; Toffoli, G.
Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers
2012-01-01 Poletto, M; DI LORETO, Carla; Marasco, D; Poletto, E; Puglisi, Fabio; Damante, Giuseppe; Tell, Gianluca
Adjuvant endocrine therapy in postmenopausal breast cancer patients: does hormone receptor status influence decision-making?
2011-01-01 Puglisi, Fabio; Minisini, A. M.
Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM)
2018-01-01 Gori, Stefania; Puglisi, Fabio; Cinquini, Michela; Pappagallo, Giovanni; Frassoldati, Antonio; Biganzoli, Laura; Cortesi, Laura; Fiorentino, Alba; Angiolini, Catia; Tinterri, Corrado; De Censi, Andrea; Levaggi, Alessia; Del Mastro, Lucia
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer
2014-01-01 Pagani, Olivia; Regan, Meredith M.; Walley, Barbara A.; Fleming, Gini F.; Colleoni, Marco; Láng, István; Gomez, Henry L.; Tondini, Carlo; Burstein, Harold J.; Perez, Edith A.; Ciruelos, Eva; Stearns, Vered; Bonnefoi, Hervé R.; Martino, Silvana; Geyer J. r., Charles E.; Pinotti, Graziella; Puglisi, Fabio; Crivellari, Diana; Ruhstaller, Thomas; Winer, Eric P.; Rabaglio Poretti, Manuela; Maibach, Rudolf; Ruepp, Barbara; Giobbie Hurder, Anita; Price, Karen N.; Bernhard, Jürg; Luo, Weixiu; Ribi, Karin; Viale, Giuseppe; Coates, Alan S.; Gelber, Richard D.; Goldhirsch, Aron; Francis, Prudence A.
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials
2023-01-01 Pagani, O.; Walley, B. A.; Fleming, G. F.; Colleoni, M.; Lang, I.; Gomez, H. L.; Tondini, C.; Burstein, H. J.; Goetz, M. P.; Ciruelos, E. M.; Stearns, V.; Bonnefoi, H. R.; Martino, S.; Geyer, C. E.; Chini, C.; Puglisi, F.; Spazzapan, S.; Ruhstaller, T.; Winer, E. P.; Ruepp, B.; Loi, S.; Coates, A. S.; Gelber, R. D.; Goldhirsch, A.; Regan, M. M.; Francis, P. A.
Adjuvant ovarian function suppression and cognitive function in women with breast cancer
2016-01-01 Phillips, Kelly Anne; Regan, Meredith M.; Ribi, Karin; Francis, Prudence A.; Puglisi, Fabio; Bellet, Meritxell; Spazzapan, Simon; Karlsson, Per; Budman, Daniel R.; Zaman, Khalil; Abdi, Ehtesham A.; Domchek, Susan M.; Feng, Yang; Price, Karen N.; Coates, Alan S.; Gelber, Richard D.; Maruff, Paul; Boyle, Frances; Forbes, John F.; Ahles, Tim; Fleming, Gini F.; Bernhard, Jürg
Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial.
2013-01-01 Crivellari, D; Gray, K; Dellapasqua, S; Puglisi, F; Ribi, K; Price, K; H, Láng; I, ; Gianni, L; Spazzapan, S; Pinotti, G; Lüthi, J; Gelber, R; Regan, M; Colleoni, M; Castiglione-Gertsch, M; Maibach, R; Rabaglio, M; Coates, A; Goldhirsch, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1781P Feasibility of an automated data solution for Binary Alignment Map (BAM) files generated through next generation sequencing (NGS) of circulating tumor DNA (ctDNA) | 1-gen-2021 | Pellizzari, L.; Rossi, N.; Verardo, M.; Spizzo, R.; Belletti, B.; Piazza, C.; Puglisi, F.; Gerratana, L. | |
| [Early breast cancer in pre-menopausal women and endocrine treatment: which factors impact on decision-making process?] | 1-gen-2015 | Bonotto, Marta; Puglisi, Fabio | |
| A Delphi consensus and open debate on the role of first-line bevacizumab for HER2-negative metastatic breast cancer | 1-gen-2016 | Puglisi, Fabio; Bisagni, Giancarlo; Ciccarese, Mariangela; Fontanella, Caterina; Gamucci, Teresa; Leo, Luigi; Molino, Annamaria; Silva, Rosa Rita; Marchetti, Paolo | |
| A fast and validated LC-MS/MS method to quantify lenvatinib in dried blood spot | 1-gen-2023 | Zanchetta, M.; Posocco, B.; Gagno, S.; Poetto, A. S.; Orleni, M.; Canil, G.; Guardascione, M.; Puglisi, F.; Toffoli, G. | |
| A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: The virtual experience of the MITO cooperative group | 1-gen-2022 | Bartoletti, M.; Bergamini, A.; Giannone, G.; Nero, C.; Musacchio, L.; Farolfi, A.; Passarelli, A.; Kuhn, E.; Castaldo, D.; Lombardo, V.; Di Palma, T.; Lorusso, D.; Puglisi, F.; De Giorgi, U.; Valabrega, G.; Schettino, C.; Scambia, G.; Capoluongo, E.; Pignata, S. | |
| A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer | 1-gen-2010 | Venturini, M; Bighin, C; Puglisi, Fabio; Olmeo, N; Aitini, E; Colucci, G; Garrone, O; Paccagnella, A; Marini, G; Crinò, L; Mansutti, M; Baconnet, B; Barbato, A; Del Mastro, L. | |
| A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer | 1-gen-2021 | Poetto, A. S.; Posocco, B.; Gagno, S.; Orleni, M.; Zanchetta, M.; Iacuzzi, V.; Canil, G.; Buzzo, M.; Montico, M.; Guardascione, M.; Basile, D.; Pelizzari, G.; Alberti, M.; Gerratana, L.; Puglisi, F.; Toffoli, G. | |
| A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study | 1-gen-2018 | Gagno, Sara; D'Andrea, Mario Rosario; Mansutti, Mauro; Zanusso, Chiara; Puglisi, Fabio; Dreussi, Eva; Montico, Marcella; Biason, Paola; Cecchin, Erika; Iacono, Donatella; Russo, Stefania; Cinausero, Marika; Saracchini, Silvana; Gasparini, Giampietro; Sartori, Donata; Bari, Mario; Collovà, Elena; Meo, Rosa; Merkabaoui, Ghassan; Spagnoletti, Ilaria; Pellegrino, Arianna; Gianni, Lorenzo; Sandri, Paolo; Cretella, Elisabetta; Vattemi, Emanuela; Rocca, Andrea; Serra, Patrizia; Fabbri, Maria Agnese; Benedetti, Giovanni; Foghini, Laura; Medici, Michele; Basso, Umberto; Amoroso, Vito; Riccardi, Ferdinando; Baldelli, Anna Maria; Clerico, Mario; Bonura, Salvatore; Saggia, Chiara; Innocenti, Federico; Toffoli, Giuseppe | |
| A novel kindred with familial gastrointestinal stromal tumors caused by a rare kit germline mutation (N655k): Clinico-pathological presentation and tki sensitivity | 1-gen-2020 | Fornasarig, M.; Gasparotto, D.; Foltran, L.; Campigotto, M.; Lombardi, S.; Del Savio, E.; Buonadonna, A.; Puglisi, F.; Sulfaro, S.; Canzonieri, V.; Cannizzaro, R.; Maestro, R. | |
| A Randomized Clinical Trial Investigating an Integrated Nursing Educational Program to Mitigate Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: The NIV-EC Trial | 1-gen-2023 | Mazzega-Fabbro, C.; Polesel, J.; Brusutti, L.; Malnis, E.; Sirelli, C.; Drigo, A.; Manicone, M.; Rizzetto, M.; Lisanti, C.; Puglisi, F. | |
| A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring | 1-gen-2021 | Zanchetta, M.; Iacuzzi, V.; Posocco, B.; Bortolin, G.; Poetto, A. S.; Orleni, M.; Canil, G.; Guardascione, M.; Foltran, L.; Fanotto, V.; Puglisi, F.; Gagno, S.; Toffoli, G. | |
| A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients | 1-gen-2018 | Pelizzari, G.; Gerratana, L.; Basile, D.; Zago, S.; Vitale, M. G.; Bartoletti, M.; Lisanti, C.; Fanotto, V.; Corvaja, C.; Bortot, L.; Liguori, A.; Cinausero, M.; Russo, S.; Andreetta, C.; Bonotto, M.; Mansutti, M.; Minisini, A. M.; Curcio, F.; Fasola, G.; Puglisi, F. | |
| A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer | 1-gen-2019 | Gagno, S.; Poletto, E.; Bartoletti, M.; Quartuccio, L.; Romualdi, C.; Garziera, M.; Scalone, S.; Sorio, R.; Dreussi, E.; Zanusso, C.; De Mattia, E.; Roncato, R.; Cecchin, E.; Giorda, G.; De Vita, S.; Dal Bo, M.; Puglisi, F.; Toffoli, G. | |
| Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers | 1-gen-2012 | Poletto, M; DI LORETO, Carla; Marasco, D; Poletto, E; Puglisi, Fabio; Damante, Giuseppe; Tell, Gianluca | |
| Adjuvant endocrine therapy in postmenopausal breast cancer patients: does hormone receptor status influence decision-making? | 1-gen-2011 | Puglisi, Fabio; Minisini, A. M. | |
| Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM) | 1-gen-2018 | Gori, Stefania; Puglisi, Fabio; Cinquini, Michela; Pappagallo, Giovanni; Frassoldati, Antonio; Biganzoli, Laura; Cortesi, Laura; Fiorentino, Alba; Angiolini, Catia; Tinterri, Corrado; De Censi, Andrea; Levaggi, Alessia; Del Mastro, Lucia | |
| Adjuvant exemestane with ovarian suppression in premenopausal breast cancer | 1-gen-2014 | Pagani, Olivia; Regan, Meredith M.; Walley, Barbara A.; Fleming, Gini F.; Colleoni, Marco; Láng, István; Gomez, Henry L.; Tondini, Carlo; Burstein, Harold J.; Perez, Edith A.; Ciruelos, Eva; Stearns, Vered; Bonnefoi, Hervé R.; Martino, Silvana; Geyer J. r., Charles E.; Pinotti, Graziella; Puglisi, Fabio; Crivellari, Diana; Ruhstaller, Thomas; Winer, Eric P.; Rabaglio Poretti, Manuela; Maibach, Rudolf; Ruepp, Barbara; Giobbie Hurder, Anita; Price, Karen N.; Bernhard, Jürg; Luo, Weixiu; Ribi, Karin; Viale, Giuseppe; Coates, Alan S.; Gelber, Richard D.; Goldhirsch, Aron; Francis, Prudence A. | |
| Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials | 1-gen-2023 | Pagani, O.; Walley, B. A.; Fleming, G. F.; Colleoni, M.; Lang, I.; Gomez, H. L.; Tondini, C.; Burstein, H. J.; Goetz, M. P.; Ciruelos, E. M.; Stearns, V.; Bonnefoi, H. R.; Martino, S.; Geyer, C. E.; Chini, C.; Puglisi, F.; Spazzapan, S.; Ruhstaller, T.; Winer, E. P.; Ruepp, B.; Loi, S.; Coates, A. S.; Gelber, R. D.; Goldhirsch, A.; Regan, M. M.; Francis, P. A. | |
| Adjuvant ovarian function suppression and cognitive function in women with breast cancer | 1-gen-2016 | Phillips, Kelly Anne; Regan, Meredith M.; Ribi, Karin; Francis, Prudence A.; Puglisi, Fabio; Bellet, Meritxell; Spazzapan, Simon; Karlsson, Per; Budman, Daniel R.; Zaman, Khalil; Abdi, Ehtesham A.; Domchek, Susan M.; Feng, Yang; Price, Karen N.; Coates, Alan S.; Gelber, Richard D.; Maruff, Paul; Boyle, Frances; Forbes, John F.; Ahles, Tim; Fleming, Gini F.; Bernhard, Jürg | |
| Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial. | 1-gen-2013 | Crivellari, D; Gray, K; Dellapasqua, S; Puglisi, F; Ribi, K; Price, K; H, Láng; I, ; Gianni, L; Spazzapan, S; Pinotti, G; Lüthi, J; Gelber, R; Regan, M; Colleoni, M; Castiglione-Gertsch, M; Maibach, R; Rabaglio, M; Coates, A; Goldhirsch, A. |